Showing results (171-180 of 447) with videos related to
Sort By:
Pageof 45
Headache|July 10, 2024
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trialsStephen D Silberstein, Hans-Christoph Diener, David W Dodick, et al.Current Pain and Headache Reports|August 11, 2023
Hemicrania Continua: An UpdateHaidar M Al-Khazali, Rune Häckert Christensen, Giorgio Lambru, et al.Headache|July 26, 2019
Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal NeuralgiaJoan Crespi, Daniel Bratbak, David W Dodick, et al.Headache|August 5, 2020
Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR)Talia A Pearl, Gina Dumkrieger, Catherine D Chong, et al.Journal of the Neurological Sciences|July 8, 2023
World Brain Day 2023 - Brain Health and Disability: "Leave no one behind"Tissa Wijeratne, David W Dodick, Steven L Lewis, et al.Headache|January 23, 2020
Sensory Hypersensitivity Symptoms in Migraine With vs Without Aura: Results From the American Registry for Migraine ResearchTalia A Pearl, Gina Dumkrieger, Catherine D Chong, et al.Cephalalgia : an International Journal of Headache|April 25, 2024
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraineDavid J Whitaker, Gina M Dumkrieger, Joseph G Hentz, et al.Cephalalgia : an International Journal of Headache|February 15, 2022
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraineLars Jacob Stovner, Knut Hagen, Erling Tronvik, et al.Journal of Neurosurgical Anesthesiology|October 10, 2009
Occipital nerve stimulator placement under general anesthesia: initial experience with 5 cases and review of the literatureTerrence L Trentman, Richard S Zimmerman, David W Dodick, et al.Vaccine|June 4, 2025
RSV vaccines and Guillain-Barré syndrome: Insights into an emerging concernCleo Anastassopoulou, Antonios-Periklis Panagiotopoulos, Stefanos Ferous, et al.Pageof 45